Rockwell Medical Raises FY2026 Sales Guidance from $65.000M-$70.000M to $70.000M-$75.000M vs $73.769M Est
Benzinga Newsdesk 6 months ago
NewsGuidance
Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual GuidanceNet Sales$70.0M to $75.0MGross Margin18% to 22%Adjusted EBITDA$1.0M to $2.0MOperating Cash FlowPositive
Rockwell Medical updates its 2026 annual guidance as follows:
| 2026 Annual Guidance | |
| Net Sales | $70.0M to $75.0M |
| Gross Margin | 18% to 22% |
| Adjusted EBITDA | $1.0M to $2.0M |
| Operating Cash Flow | Positive |